FR2899103A1 - Utilisation cosmetique de d-ribose - Google Patents
Utilisation cosmetique de d-ribose Download PDFInfo
- Publication number
- FR2899103A1 FR2899103A1 FR0602675A FR0602675A FR2899103A1 FR 2899103 A1 FR2899103 A1 FR 2899103A1 FR 0602675 A FR0602675 A FR 0602675A FR 0602675 A FR0602675 A FR 0602675A FR 2899103 A1 FR2899103 A1 FR 2899103A1
- Authority
- FR
- France
- Prior art keywords
- ribose
- cosmetic composition
- skin
- use according
- optimizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title claims abstract description 107
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 title claims abstract description 52
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 239000002537 cosmetic Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 210000004927 skin cell Anatomy 0.000 title claims abstract description 10
- 230000037303 wrinkles Effects 0.000 title claims description 12
- 210000003491 skin Anatomy 0.000 title claims description 5
- 239000013543 active substance Substances 0.000 title claims description 4
- 230000019522 cellular metabolic process Effects 0.000 title abstract description 3
- 230000004060 metabolic process Effects 0.000 claims description 10
- 230000002407 ATP formation Effects 0.000 claims description 5
- 230000004098 cellular respiration Effects 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 3
- 230000037394 skin elasticity Effects 0.000 claims description 3
- 239000002932 luster Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 17
- 206010040954 Skin wrinkling Diseases 0.000 description 11
- 238000005259 measurement Methods 0.000 description 7
- 206010021143 Hypoxia Diseases 0.000 description 6
- 230000007954 hypoxia Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- -1 sticks Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000006567 cellular energy metabolism Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000006540 mitochondrial respiration Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000001314 profilometry Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0602675A FR2899103B1 (fr) | 2006-03-28 | 2006-03-28 | Utilisation cosmetique de d-ribose |
US11/690,707 US20070231288A1 (en) | 2006-03-28 | 2007-03-23 | Cosmetic use of d-ribose and method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0602675A FR2899103B1 (fr) | 2006-03-28 | 2006-03-28 | Utilisation cosmetique de d-ribose |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2899103A1 true FR2899103A1 (fr) | 2007-10-05 |
FR2899103B1 FR2899103B1 (fr) | 2008-12-12 |
Family
ID=37434327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0602675A Active FR2899103B1 (fr) | 2006-03-28 | 2006-03-28 | Utilisation cosmetique de d-ribose |
Country Status (2)
Country | Link |
---|---|
US (1) | US20070231288A1 (fr) |
FR (1) | FR2899103B1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
US20090197819A1 (en) * | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
US20090232750A1 (en) * | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
US8911774B2 (en) * | 2009-05-18 | 2014-12-16 | Cellhealth Technologies Ltd. | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use |
JP6507158B2 (ja) | 2013-10-24 | 2019-04-24 | ザ プロクター アンド ギャンブル カンパニー | 皮膚を明るくする化粧組成物 |
WO2017004102A1 (fr) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Produit de soin de la peau multi-constituant comprenant du nicotinamide riboside dans un récipient à chambres multiples |
CN115414273B (zh) | 2016-01-11 | 2024-01-30 | 宝洁公司 | 处理皮肤状况的方法以及用于其的组合物 |
EP3641725A1 (fr) | 2017-06-23 | 2020-04-29 | The Procter and Gamble Company | Composition et procédé permettant d'améliorer l'aspect de la peau |
CN112437657A (zh) | 2018-07-03 | 2021-03-02 | 宝洁公司 | 处理皮肤状况的方法 |
CN111228130B (zh) * | 2019-10-28 | 2022-09-30 | 北京皓尔生物科技有限公司 | 一种具有激发皮肤细胞能量、修复皮肤屏障功效的组合物及其制备方法与应用 |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
JP2023528616A (ja) | 2020-06-01 | 2023-07-05 | ザ プロクター アンド ギャンブル カンパニー | ビタミンb3化合物の皮膚への浸透を改善する方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
EP1417954A1 (fr) * | 2002-10-18 | 2004-05-12 | Bernhard Heising | Compositions cosmétiques contenant le ribose |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8503941A1 (es) * | 1982-10-27 | 1985-04-16 | Crinos Industria Farmaco | Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados |
FR2800611B1 (fr) * | 1999-11-08 | 2002-10-11 | Oreal | Composition a application topique contenant un sucre, et ses utilisations cosmetiques |
US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
-
2006
- 2006-03-28 FR FR0602675A patent/FR2899103B1/fr active Active
-
2007
- 2007-03-23 US US11/690,707 patent/US20070231288A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
EP1417954A1 (fr) * | 2002-10-18 | 2004-05-12 | Bernhard Heising | Compositions cosmétiques contenant le ribose |
Also Published As
Publication number | Publication date |
---|---|
US20070231288A1 (en) | 2007-10-04 |
FR2899103B1 (fr) | 2008-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2899103A1 (fr) | Utilisation cosmetique de d-ribose | |
EP1064931B1 (fr) | Composition cosmétique comprenant au moins un hydroxystilbene et de l'acide ascorbique | |
EP0737199B1 (fr) | Procede de preparation de composes de silicium biologiquement actifs sous forme concentree | |
EP1021161B1 (fr) | Utilisation de l'acide ellagique et de ses derives en cosmetique et en dermatologie | |
FR3000670A1 (fr) | Composition cosmetique apaisante a base d'acide salicylique. | |
US20080312169A1 (en) | Cosmetic use of D-ribose | |
CA2266796A1 (fr) | Utilisation d'au moins un hydroxystilbene dans une composition raffermissante | |
EP2038013B1 (fr) | Composition cosmetique a base d'acide gras polyinsatures et ses utilisations | |
EP1195156A1 (fr) | Utilisation d'un extrait d'Ericaceae pour traíter les signes du vieillissement cutané | |
FR2799370A1 (fr) | Utilisation du lycopene dans des compositions destinees a traiter les signes cutanes du vieillissement | |
US20100189675A1 (en) | Cosmetic use of an imidopercarboxylic acid derivative as desquamating agent | |
FR3018191A1 (fr) | Utilisations cosmetiques de la swertiamarine | |
FR2975006A1 (fr) | Composition cosmetique ou dermatologique a base d'extraits d'immortelle et son utilisation | |
FR3011469A1 (fr) | Utilisation cosmetique et/ou dermatologique d'un extrait d'hamamelis virginiana | |
FR2898807A1 (fr) | Composition comprenant de l'hydroxyapatite et un sel de calcium pour renforcer la fonction barriere de la peau et/ou des semi-muqueuses | |
WO2017178751A1 (fr) | Utilisation cosmétique d'un extrait de khaya senegalensis | |
FR2973230A1 (fr) | Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau | |
CN112451403B (zh) | 依克多因及4-甲氧基水杨酸钾的组合在化妆品中的应用 | |
FR2954702A1 (fr) | Agent stimulant l'expression de loxl | |
FR2903009A1 (fr) | Composition cosmetique et/ou dermatologique associant un derive de c-glycoside et un agent desquamant | |
FR3005408A1 (fr) | Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette lies aux modifications du tissu adipeux | |
FR3004347A1 (fr) | Composition cosmetique comprenant une huile essentielle de sauge et son utilisation | |
FR2977158A1 (fr) | Utilisation d'huile essentielle de bursera graveolens | |
WO2013098519A2 (fr) | Utilisation d'une composition pour prevenir et lutter contre les effets du tabac sur la peau | |
WO2004075821A2 (fr) | Utilisation cosmetique d'inositol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CD | Change of name or company name |
Owner name: LUCAS MEYER COSMETICS Effective date: 20120613 |
|
TP | Transmission of property |
Owner name: LUCAS MEYER COSMETICS Effective date: 20120613 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |